Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sarcoma × Conservative Treatment × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Chalazion 3 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Sarcoma 1 Pilonidal Sinus 1 Necrosis 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Mucinoses 1 Ganglion Cysts 1 Fistula 1 Connective Tissue Diseases 1 Breast Neoplasms 1

Interventions

Doxorubicin 119 Ifosfamide 70 Radiotherapy 64 Cyclophosphamide 61 Gemcitabine 53 Filgrastim 46 Docetaxel 34 pazopanib 33 Etoposide 33 pembrolizumab 32 Trabectedin 31 Vincristine 30 Cisplatin 29 Nivolumab 27 Irinotecan 21 Magnetic Resonance Spectroscopy 20 Carboplatin 20 Ipilimumab 19 Temozolomide 17 Radiation 16 Mesna 16 Melphalan 16 Bevacizumab 16 Sirolimus 15 Granulocyte Colony-Stimulating Factor 15 Dactinomycin 15 Biopsy 15 Topotecan 14 Surgical Procedures, Operative 14 Sorafenib 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06022159 2025-06-05

HYPOSARC

Institut Claudius Regaud

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡